| 1 |
Britton M. The epidemiology of mesothelioma[J]. Semin Oncol, 2002, 29(1): 18-25.
|
| 2 |
Baratti D, Kusamura S, Deraco M. Diffuse malignant peritoneal mesothelima: systematic review of clinical management and biological reseach[J]. J Surg Oncol, 2011, 103(8): 822-831.
|
| 3 |
Monteagudo C, Merino MJ, San-Juan J, et al.Immunohisto-chemical distribution of collagenaseⅣinormal, benign and malignant breast tissue[J]. Am J Pathol, 990, 136(3): 585-592.
|
| 4 |
Zhang K, Chen D, Jiao X, et al.Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling[J]. Lab Invest, 2011, 91(3): 426-483.
|
| 5 |
Zeng ZS, Cohen AM, Zhang ZF, et al.Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlats with lymph node and distant metastases[J]. Clin Cancer Res, 1995, 1(8): 899-906.
|
| 6 |
Gaafar R, Bahnassy A, Abdelsalam I, et al.Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma[J]. Lung Cancer, 2010, 70(1): 43-50.
|
| 7 |
Husain AN, Colby T, Ordonez N, et al.Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group[J]. Arch Pathol Lab Med.2013, 137(5): 647-667.
|
| 8 |
Raptopoulos V. Peritoneal mesothelioma[J]. Crit Rev Diagn Imaging, 1985, 24(4): 293-328.
|
| 9 |
魏思忱，郑国启，白文元．恶性腹膜间皮瘤的研究进展[J]．中华消化杂志，2014，34(3)：212-214.
|
| 10 |
宋慧，郑国启，魏思忱，等．以局部炎症为首发症状的恶性腹膜间皮瘤患者的临床特征[J]．中华肿瘤杂志，2014，36(4)：312-313.
|
| 11 |
梁育飞，郑国启，李春英，等．局限性腹膜间皮瘤22例临床分析[J]．中国综合临床，2014，30(9)：953-956.
|
| 12 |
郑国启，张国尊，刘雅刚，等．恶性腹膜问皮瘤1 4例临床分析[J]．中华消化杂志，2014，34(4)：266-269.
|
| 13 |
Yin WJ, Zheng GQ, Chen YF, et al.CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis[J]. Radiol Med, 2016, 121(4): 253-260.
|
| 14 |
Yu-Fei L, Guo-Qi Z, Yue-Feng C, et al.CT differentiation of diffuse malignant peritoneal mesothelioma and peritonealcarcinomatosis[J]. J Gastroenterol Hepatol, 2016, 31(4): 709-715.
|
| 15 |
Munkholm-Larsen S, Cao CQ, Yan TD.Malignant peritoneal mesothelioma[J]. World J Gastrointest Surg, 2009, 1(1): 38-48.
|
| 16 |
Busch JM, Kruskal JB, Wu B, et al.Best cases from the AFIP.Malignant peritoneal mesothelioma[J]. Radiographics, 2002, 22(6): 1511-1515.
|
| 17 |
魏思忱，郑国启，王志刚，等．沧州地区162例腹膜恶性间皮瘤临床资料回顾性分析[J]．中华内科杂志，2013，52(7)：599-600.
|
| 18 |
Pillai K, Pourgholami MH, Chua TC, et al.Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma[J]. J Cancer Res Clin Oncol, 2013, 139(6): 117-120.
|
| 19 |
Yu G, Wang J, Chen Y, et al.Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer[J]. Clin Exp Metastasis, 2008, 25(7): 695-702.
|
| 20 |
Setnrliehi MD, Weht Z. How matrix meatlloporetinaseser regulate cell behavior [J]. Annu Rev Cell Dev Biol, 2001, 17: 463-516.
|
| 21 |
Davies B, Miles DW, Happefield LG, et al.Activity of type IV collagenases in benign and malignant breast diease[J]. Br J Cancer, 1993, 67(5): 1126-1131.
|
| 22 |
Mineta H, Borg A, Dictor M, et al.Correlation between p53 mutation neck squamous cell carcinoma cyclin D 1 amplification in neck squamous cell carcinoma[J]. Oral Oncol, 1997, 33(1): 42-46.
|
| 23 |
Enomoto Y, Kasai T, Takeda M, et al.A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma[J]. Pathol Int, 2012, 62(4): 226-231.
|
| 24 |
Rena O, Boldorini LR, Gaudino E, et al.Epidermal growth factor receptor over-expression in malignant pleural mesothlioma: prognostic correlations[J]. J Surg Oncol, 2011, 104(6): 701-705.
|